NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

失眠药物治疗的全球市场:按治疗进行的市场调查(非处方助眠药和处方助眠药),展望(-2025年),COVID-19的累积影响

Insomnia Pharmacological Treatment Market Research Report by Treatment (Over-the-Counter Sleep Aids and Prescription Sleep Aids) - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品编码 973187
出版日期 内容资讯 英文 181 Pages
商品交期: 最快1-2个工作天内
价格
失眠药物治疗的全球市场:按治疗进行的市场调查(非处方助眠药和处方助眠药),展望(-2025年),COVID-19的累积影响 Insomnia Pharmacological Treatment Market Research Report by Treatment (Over-the-Counter Sleep Aids and Prescription Sleep Aids) - Global Forecast to 2025 - Cumulative Impact of COVID-19
出版日期: 2021年02月04日内容资讯: 英文 181 Pages
简介

失眠药物治疗的市场规模预计将从2019年的7,148.13百万美元增长到5.67%的年均增长率(CAGR),到2025年底达到9,952.73百万美元。

市场细分和覆盖率

该研究报告对失眠的药物治疗进行了分类,预测了利润并分析了以下每个子市场的趋势。

  • 治疗在子市场中,市场分为非处方睡眠助剂和处方睡眠助剂。通过抗组胺药,褪黑激素和缬草根进一步对非处方睡眠助剂进行分类和调查。规定的睡眠助剂被分类和研究为苯二氮卓类,褪黑激素受体拮抗剂,非苯二氮卓类和油性毒素拮抗剂。
  • 按地区将其分类并调查了美洲,亚太地区,欧洲和中东/非洲。美洲地区正在阿根廷,巴西,加拿大,墨西哥和美国进行调查。在澳大利亚,中国,印度,印度尼西亚,日本,马来西亚,菲律宾,韩国和泰国对亚太地区进行了调查。欧洲是法国,德国,西班牙,意大利,荷兰,俄罗斯和英国,而中东和非洲是卡塔尔,沙特阿拉伯,南非和阿拉伯联合酋长国。

企业可用性概况

该调查由EEbb Therapeutics、Eisai Co.、Ltd.、Meda Consumer Healthcare, Inc、Merck & Co., Inc.、Mylan NV、Paratek Pharmaceuticals, Inc.、 Pernix Therapeutics、 Pfizer Inc.、 Purdue Pharmaceuticals L.P.、 Sanofi S.A.、 Sumitomo Dainippon Pharma Co., Ltd.、 Takeda Pharmaceuticals Company Ltd.、???Vanda Pharmaceuticals.都在深入探索全球市场领先厂商最近的重大发展和创新概况。

FPNV定位矩阵

FPNV定位矩阵可帮助公司制定更好的决策,并通过业务战略(业务增长,行业覆盖范围,财务可行性,渠道支持)和产品满意度来瞭解竞争格局。根据(成本性能,易用性,产品功能和客户支持)对我们市场中的供应商进行评估和分类。

竞争战略窗口(竞争战略窗口)

竞争战略窗口从市场,应用和区域角度分析了竞争格局。这有助于供应商定义能力和机会之间的协调或适应,以实现未来的增长前景。在预测期内,供应商将采用持续的并购策略,区域扩展,研发和新产品实施策略,以最佳或有利地适应进一步的业务扩展和增长。

COVID-19的累积影响

预计COVID-19将在预测期内对行业增长产生长期影响,因为这是无与伦比的全球公共卫生突发事件,几乎影响了每个行业。我们正在进行的研究扩大了研究框架,以确保它包括潜在的COVID-19问题和潜在的未来路径。这项研究提供了对COVID-19的见解,同时考虑了不断变化的消费者行为和需求,购买模式,供应链重新路由,当前市场势力动态以及政府的关键干预措施。更新后的调查提供了见解,分析,估计和预测,其中考虑了COVID-19对市场的影响。

该调查提供了有关以下准则的见解:

  • 1.市场渗透率:主要参与者提供的有关市场的全面信息
  • 2.市场开发:有利可图的新兴市场的详细信息和市场分析
  • 3.市场多元化:有关新产品发布,欠发达地区,最新发展和投资的更多信息
  • 4.竞争评估和情报:全面评估主要公司的市场份额,战略,产品和制造能力
  • 5.产品开发和创新:对未来技术,研发活动和新产品开发的智能见解

该调查回答了以下问题

  • 1. 失眠药物治疗的全球市场规模和预测是什么?
  • 2. 在预测期内,构成市场的COVID-19有哪些障碍和影响?
  • 3. 在预测期内,您将投资哪些产品,细分,应用或领域?
  • 4. 什么是市场机会的竞争战略窗口?
  • 5. 什么是市场技术趋势和监管框架?
  • 6. 您认为适合进入市场的方式和战略举措是什么?

本报告调查了失眠药物治疗的全球市场,概述了市场,分析了市场增长和障碍,市场机会,市场规模趋势以及按治疗和地区,竞争情况做出的预测,它提供系统信息,例如主要公司的概况。

目录

第1章序言

  • 调查目的
  • 市场细分和覆盖范围
  • 调查对像年度
  • 货币和价格
  • 语言
  • 利益相关者

第2章调查方法

  • 调查过程
    • 定义:调查目的
    • 决策:调查设计
    • 准备:测量设备
    • 集合:数据源
    • 分析:数据解释
    • 配方:数据验证
    • 发布:调查报告
    • 重复:更新报告
  • 进行调查
    • 开始:调查过程
    • 计划:创建调查计划
    • 执行:进行调查
    • 验证:发现和分析
    • 出版物:调查报告
  • 调查结果

第3章执行摘要

  • 简介
  • 市场前景
  • 治疗前景
  • 区域展望
  • 竞争对手展望

第4章市场概述

  • 简介

第5章市场动态

  • 简介
  • 促进因素
    • 压力增加和身体残疾
    • 成人慢性失眠的患病率
    • 增强患者对失眠的认识并增加就诊
  • 抑制器
    • 药物相关的副作用
  • 市场机会
    • 新产品开发
    • 新药在发展中地区的渗透率提高
  • 挑战
    • 在某些患者中失眠的个人水平污名

第6章市场洞察

  • 波特五力分析
    • 新进入者的威胁
    • 替代威胁
    • 客户的议价能力
    • 供应商的谈判能力
    • 行业竞争
  • COVID-19的累积效果
  • 客户端定制

第7章按治疗

  • 简介
  • 非处方睡眠帮助
    • 抗组胺药
    • 褪黑激素
    • 缬草根
  • 处方助眠药
    • 苯二氮卓
    • 褪黑激素受体拮抗剂
    • 非苯二氮卓
    • Orexin拮抗剂

第8章美洲

  • 简介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太地区

  • 简介
  • 澳大利亚
  • 中国
  • 印度
  • 印度尼西亚
  • 日本
  • 马来西亚
  • 菲律宾
  • 韩国
  • 泰国

第10章欧洲,中东/非洲

  • 简介
  • 法国
  • 德国
  • 意大利
  • 荷兰
  • 卡塔尔
  • 俄罗斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯联合酋长国
  • 英国

第11章竞争情况

  • FPNV定位矩阵
    • 象限
    • 经营策略
    • 产品满意度
  • 市场排名分析
  • 市场占有率分析
  • 竞争情景
    • 并购
    • 协议,合作和伙伴关系
    • 推出和增强新产品
    • 投融资
    • 奖项,表彰,扩展

第12章企业可用性简介

  • Ebb Therapeutics
  • Eisai Co., Ltd.
  • Meda Consumer Healthcare, Inc
  • Merck & Co., Inc.
  • Mylan N.V.
  • Paratek Pharmaceuticals, Inc.
  • Pernix Therapeutics
  • Pfizer Inc.
  • Purdue Pharmaceuticals L.P.
  • Sanofi S.A.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Takeda Pharmaceuticals Company Ltd.
  • Vanda Pharmaceuticals

第13章附录

  • 讨论指南
目录
Product Code: MRR-E792FFF

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Insomnia Pharmacological Treatment Market is expected to grow from USD 7,530.46 Million in 2020 to USD 9,863.52 Million by the end of 2025.

2. The Global Insomnia Pharmacological Treatment Market is expected to grow from EUR 6,602.85 Million in 2020 to EUR 8,648.52 Million by the end of 2025.

3. The Global Insomnia Pharmacological Treatment Market is expected to grow from GBP 5,869.95 Million in 2020 to GBP 7,688.55 Million by the end of 2025.

4. The Global Insomnia Pharmacological Treatment Market is expected to grow from JPY 803,691.64 Million in 2020 to JPY 1,052,687.61 Million by the end of 2025.

5. The Global Insomnia Pharmacological Treatment Market is expected to grow from AUD 10,935.23 Million in 2020 to AUD 14,323.14 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Insomnia Pharmacological Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment, the Insomnia Pharmacological Treatment Market studied across Over-the-Counter Sleep Aids and Prescription Sleep Aids. The Over-the-Counter Sleep Aids further studied across Antihistamines, Melatonin, and Valerian Roots. The Prescription Sleep Aids further studied across Benzodiazepines, Melatonin Receptor Antagonists, Non-benzodiazepines, and Orexin Antagonists.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Insomnia Pharmacological Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Insomnia Pharmacological Treatment Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Insomnia Pharmacological Treatment Market including Aa Pharma Inc, Actavis Totowa LLC, Altimed Pharma Inc., Amneal Pharmaceuticals NY LLC, Direct_Rx, Ebb Therapeutics, Eisai Co., Ltd., Foxland Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Hospira, Inc., Ingenus Pharmaceuticals, LLC, Meda Consumer Healthcare, Inc, MEDA Pharmaceuticals, MedPointe Pharmaceuticals, Merck & Co., Inc., Micro Labs Limited, Mylan N.V., Paratek Pharmaceuticals, Inc., Pernix Therapeutics, Pfizer Inc., Pro Doc Limitee, Purdue Pharmaceuticals L.P., Remedy Repack, Sanofi S.A., Sivem Pharmaceuticals Ulc, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceuticals Company Ltd., TriVue Pharmaceuticals, Inc., Vanda Pharmaceuticals, and Winthrop U.S..

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Insomnia Pharmacological Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Insomnia Pharmacological Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insomnia Pharmacological Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insomnia Pharmacological Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Insomnia Pharmacological Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Insomnia Pharmacological Treatment Market?

6. What are the modes and strategic moves considered suitable for entering the Global Insomnia Pharmacological Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Treatment Outlook
  • 3.4. Geography Outlook
  • 3.5. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing stress level and physical disorders
      • 5.1.1.2. Prevalence of chronic insomnia in adult patients
      • 5.1.1.3. Rising awareness among patient and increasing visits to doctor regarding to insomnia
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel products
      • 5.1.3.2. Increase in penetration of new pharmaceuticals in developing areas
    • 5.1.4. Challenges
      • 5.1.4.1. Individual level stigma about insomnia in some patients
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Insomnia Pharmacological Treatment Market, By Treatment

  • 6.1. Introduction
  • 6.2. Over-the-Counter Sleep Aids
    • 6.2.1. Antihistamines
    • 6.2.2. Melatonin
    • 6.2.3. Valerian Roots
  • 6.3. Prescription Sleep Aids
    • 6.3.1. Benzodiazepines
    • 6.3.2. Melatonin Receptor Antagonists
    • 6.3.3. Non-benzodiazepines
      • 6.3.3.1. Eszopiclone
      • 6.3.3.2. Zaleplon
      • 6.3.3.3. Zolpidem
    • 6.3.4. Orexin Antagonists

7. Americas Insomnia Pharmacological Treatment Market

  • 7.1. Introduction
  • 7.2. Argentina
  • 7.3. Brazil
  • 7.4. Canada
  • 7.5. Mexico
  • 7.6. United States

8. Asia-Pacific Insomnia Pharmacological Treatment Market

  • 8.1. Introduction
  • 8.2. Australia
  • 8.3. China
  • 8.4. India
  • 8.5. Indonesia
  • 8.6. Japan
  • 8.7. Malaysia
  • 8.8. Philippines
  • 8.9. South Korea
  • 8.10. Thailand

9. Europe, Middle East & Africa Insomnia Pharmacological Treatment Market

  • 9.1. Introduction
  • 9.2. France
  • 9.3. Germany
  • 9.4. Italy
  • 9.5. Netherlands
  • 9.6. Qatar
  • 9.7. Russia
  • 9.8. Saudi Arabia
  • 9.9. South Africa
  • 9.10. Spain
  • 9.11. United Arab Emirates
  • 9.12. United Kingdom

10. Competitive Landscape

  • 10.1. FPNV Positioning Matrix
    • 10.1.1. Quadrants
    • 10.1.2. Business Strategy
    • 10.1.3. Product Satisfaction
  • 10.2. Market Ranking Analysis
  • 10.3. Market Share Analysis
  • 10.4. Competitor SWOT Analysis
  • 10.5. Competitive Scenario
    • 10.5.1. Merger & Acquisition
    • 10.5.2. Agreement, Collaboration, & Partnership
    • 10.5.3. New Product Launch & Enhancement
    • 10.5.4. Investment & Funding
    • 10.5.5. Award, Recognition, & Expansion

11. Company Usability Profiles

  • 11.1. Aa Pharma Inc
  • 11.2. Actavis Totowa LLC
  • 11.3. Altimed Pharma Inc.
  • 11.4. Amneal Pharmaceuticals NY LLC
  • 11.5. Direct_Rx
  • 11.6. Ebb Therapeutics
  • 11.7. Eisai Co., Ltd.
  • 11.8. Foxland Pharmaceuticals, Inc.
  • 11.9. Fresenius Kabi USA, LLC
  • 11.10. Hospira, Inc.
  • 11.11. Ingenus Pharmaceuticals, LLC
  • 11.12. Meda Consumer Healthcare, Inc
  • 11.13. MEDA Pharmaceuticals
  • 11.14. MedPointe Pharmaceuticals
  • 11.15. Merck & Co., Inc.
  • 11.16. Micro Labs Limited
  • 11.17. Mylan N.V.
  • 11.18. Paratek Pharmaceuticals, Inc.
  • 11.19. Pernix Therapeutics
  • 11.20. Pfizer Inc.
  • 11.21. Pro Doc Limitee
  • 11.22. Purdue Pharmaceuticals L.P.
  • 11.23. Remedy Repack
  • 11.24. Sanofi S.A.
  • 11.25. Sivem Pharmaceuticals Ulc
  • 11.26. Sumitomo Dainippon Pharma Co., Ltd.
  • 11.27. Takeda Pharmaceuticals Company Ltd.
  • 11.28. TriVue Pharmaceuticals, Inc.
  • 11.29. Vanda Pharmaceuticals
  • 11.30. Winthrop U.S.

12. Appendix

  • 12.1. Discussion Guide
  • 12.2. License & Pricing

List of Figures

  • FIGURE 1. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MARKET DYNAMICS
  • FIGURE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
  • FIGURE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
  • FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2025
  • FIGURE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2020 VS 2025 (USD MILLION)
  • FIGURE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, 2020 VS 2025 (USD MILLION)
  • FIGURE 25. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 28. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 30. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 31. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 32. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 33. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 34. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 35. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 36. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 38. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 39. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 40. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 48. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 50. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 62. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 63. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: SCORES
  • TABLE 49. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: BUSINESS STRATEGY
  • TABLE 50. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PRODUCT SATISFACTION
  • TABLE 51. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RANKING
  • TABLE 52. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MERGER & ACQUISITION
  • TABLE 53. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 54. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 55. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: INVESTMENT & FUNDING
  • TABLE 56. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 57. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: LICENSE & PRICING